Anomalous coronary arteries are rare angiographic findings, especially during acute myocardial infarction (MI). We present the first case of simultaneous-kissing-stent deployment in an anomalous coronary (left circumflex/obtuse marginal bifurcation with 360? loop) during an acute MI. Subsequently, staged transradial stenting of the left anterior descending artery was performed. This procedure, likewise, has not been previously described. Our case simultaneously illustrates the feasibility of both transfemoral and transradial approaches for anomalous coronary intervention in the same patient. The epidemiology and pathophysiology of anomalous coronary arteries are reviewed, with emphasis on anatomic classifications, as well as their associated cardiac mortality risks.
Learning objectives 1. Describe why, when, with whom, and where to use a vena cava filter
2. Discuss why imaging the vena cava is important 3. Compare and contrast “tried and true” vs state-of-the-art technology
4. Utilize appropriate techniques for placing and retrieving filters 5.Avoid complications in the use of vena cava filters.
6. Explore ways to build successful referral patterns.
This activity is supported by an educational grant from Cook Incorporated and has been designed for Interventional Cardiology, Vascular Surgeons, Fellows and Interventional Cardiovascular Nurses and Technologists.
Topics 1. EVA-3S & Space-Bumps in the road 2. CAPTURE 3500-Lesion morphology & Predictors for Stroke 3. CAPTURE II vs. EXACT 1500-Does open or Closed Cell Stent design really matter?
This activity has been developed for Interventional Cardiologists, Vascular Surgeons, Interventional Radiologists, Neurologists, Interventional Nurses and Technologists with an interest in the diagnosis and treatment of peripheral artery disease.
This activity has been developed for Interventional Cardiologists, Vascular Surgeons, Interventional Radiologists, Podiatric Physicians, Endovascular Allied Professionals, Endocrinologists, Wound Care Specialists, Directors of the Wound Care Clinic, and Primary Care Physicians, Pharmacists, Nurses and Technologists.
This activity has been developed for Physicians, Pharmacists, Nurses, and Technologists with an interest in the diagnosis and treatment of peripheral artery disease.
This activity has been developed for Physicians, Pharmacists, Nurses, and Technologists with an interest in the diagnosis and treatment of peripheral artery disease.
Presented By: Tony Das, MD, Director of Peripheral Interventions, Presbyterian Hospital
ARTICLES
NEWS
Clinical Review Management of Femoropopliteal Occlusive Disease in the Endovascular Era
Jeffrey Kalish, MD and Frank Pomposelli, MD
Chronic lower-extremity ischemia affects approximately 10% of patients over the age of 70, with the total number of affected patients exceeding 10 million. Within this group, only a fraction of patients have symptoms consistent with intermittent claudication, and even fewer of these ultimately present to a physician with complaints related to their arterial disease. In addition to the functional limitations caused by pain with walking, many patients fear limb loss as an ultimate complication and outcome.
Case Study and Review: Power-Pulse Spray and Angiojet Thrombectomy in Massive Inferior Vena Cava and Bilateral Lower Extremity Deep Venous Thrombosis 1,2,3Mohsen Sharifi, MD, 2Mahshid Mehdipour, 1David Skloven, MD, 1Neil Kramer, MD, 1Alphonse Ambrosia, DO, 3Mark Starling, MD
Venous thromboembolism (VTE) is a grossly underdiagnosed disease associated with high mortality and morbidity. Despite tremendous advances in the interventional field, no significant changes have occurred on a wide scale in the approach to this entity over the last few decades.
Feature:
Agreement of Community-Performed Ankle Brachial Pressure Indices (ABPI) with Vascular Laboratory Performed Assessment
Usman Jaffer, MD, Abdul Wahab Elmagrabi, MD, Alan Cameron, MD, Isamuddin Osman, MD
ccurate ABPI measurement is fundamental to the community management of suspected peripheral arterial occlusive disease. This study investigates the correlation and agreement of GP performed ABPI measurements in the community compared to those measured in the vascular laboratory (VL) in the setting of a UK district general hospital.
Terumo Partners with GHX for More Efficient Electronic Ordering Capabilities
SOMERSET, NJ – Terumo Interventional Systems, a strategic business unit of Terumo Medical Corporation (TMC), announces a new partnership between TMC and Global Health Exchange (GHX); expanding its reputation for supplying technologically advanced quality to supply chain management.
Working with GHX and its Electronic Data Interchange (EDI) system, Terumo Interventional Systems is looking to deliver providers what they want—when they want it. Through this e-commerce platform’s unique, streamlined process, hospitals are now easily able to place orders, generate receipts, and change and track orders with Terumo.
ANGIODYNAMICS ANNOUNCES PLAN TO LAUNCH
NEVERTOUCH™ VENACURE® PRODUCT LINE
QUEENSBURY, N.Y. (April 2, 2007) – AngioDynamics, Inc. (NASDAQ: ANGO) announced today plans to launch the NeverTouch VenaCure procedure kit for laser treatment of severe varicose veins. The improved VenaCure design will employ a proprietary laser fiber technology designed to provide an enhanced level of perforation protection by further preventing contact between the fiber tip and the vessel wall during treatment.
Press Release: Targeted Renal Therapy for Patients at Risk for Contrast-Induced NephropathyMulticenter Registry Results Presented at Society of Interventional Radiology Meeting
Data from a multicenter registry of targeted renal therapy (TRT™) in patients at high risk for contrast-induced nephropathy (CIN) – a significant cause of kidney failure and a large unmet market need
First International Trial of Drug-Eluting Peripheral Artery Stent Results Encouraging
Cook Medical’s ZILVER PTX Paclitaxel-Eluting Stent (DES) trial results demonstrated no stent fractures. The major adverse event (MAE) rate was equivalent to conventional balloon angioplasty treatment at its six-month follow-up point, as reported by the trial’s national principal investigator.
This activity is designed for Invasive Cardiologists, Vascular Surgeons, Interventional Neurologists, Interventional Radiologists, Nurses and Technologists.
Topics include direct thrombin inhibition, use of direct thrombin inhibitors during PPI, and adjunctive pharmacology during carotid artery stenting.
Dr. Zvonimir Krajcer is a Clinical Professor of Medicine at Baylor College of Medicine and at the University of Texas Health Science Center in Houston. Dr. Krajcer has pioneered a technique of non-surgical repair of abdominal aortic aneurysms with stent grafts. His special area of interest is non-surgical treatment of peripheral vascular disease with stents and stent grafts.
SPECIAL SUPPLEMENT: 
Complimentary Accredited Booklet and CD-Rom
Using Advanced Technology to
Treat Occluded Below-the-Knee Arteries
Superior Mesenteric Artery Revascularization and
Retrograde Visualization
